Uniplan Investment Counsel’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.32M Buy
188,330
+5,493
+3% +$128K 0.5% 58
2026
Q1
$3.49M Sell
182,837
-11,780
-6% -$260K 0.36% 72
2025
Q4
$4.71M Sell
194,617
-146
-0.1% -$3.82K 0.47% 62
2025
Q3
$4.97M Sell
194,763
-31,905
-14% -$757K 0.49% 60
2025
Q2
$4.88M Sell
226,668
-20,710
-8% -$467K 0.49% 51
2025
Q1
$5.65M Buy
247,378
+1,861
+0.8% +$49K 0.55% 49
2024
Q4
$6.37M Sell
245,517
-3,132
-1% -$77.9K 0.59% 45
2024
Q3
$6.23M Sell
248,649
-4,095
-2% -$96.7K 0.54% 45
2024
Q2
$5.42M Sell
252,744
-1,116
-0.4% -$21.7K 0.49% 50
2024
Q1
$4.71M Buy
253,860
+6,493
+3% +$114K 0.37% 60
2023
Q4
$4.13M Sell
247,367
-13,712
-5% -$175K 0.31% 67
2023
Q3
$3.67M Buy
261,079
+775
+0.3% +$12.2K 0.28% 74
2023
Q2
$5.75M Sell
260,304
-1,202
-0.5% -$25.3K 0.42% 60
2023
Q1
$5.69M Buy
261,506
+37,289
+17% +$839K 0.4% 58
2022
Q4
$4.08M Buy
224,217
+89,669
+67% +$1.85M 0.29% 76
2022
Q3
$3.06M Sell
134,548
-388
-0.3% -$8.3K 0.23% 85
2022
Q2
$1.86M Buy
+134,936
New +$1.98M 0.13% 111

Other funds holding BLFS

Uniplan Investment Counsel's BLFS Position: Q2 2026 in Review

Uniplan Investment Counsel increased its BioLife Solutions (BLFS) stake by 3% in Q2 2026, buying an estimated $128K and bringing the position to 188,330 shares worth $5.32M. The position accounts for 0.5% of the portfolio, ranked #58.

Uniplan Investment Counsel first reported a position in BLFS in Q2 2022 and has held it in 17 quarters since. The position peaked at $6.37M in Q4 2024. 217 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Uniplan Investment Counsel held 188,330 shares of BioLife Solutions worth $5.32M as of Q2 2026.
  • Uniplan Investment Counsel bought 5,493 BioLife Solutions shares in Q2 2026, an estimated $128K.
  • BioLife Solutions made up 0.5% of Uniplan Investment Counsel's portfolio in Q2 2026, its #58 holding.
  • Uniplan Investment Counsel first reported a position in BioLife Solutions in Q2 2022 and has held it in 17 quarters since.
  • Uniplan Investment Counsel's BioLife Solutions position peaked at $6.37M in Q4 2024.
  • 217 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Uniplan Investment Counsel's 13F filing for Q2 2026, filed 13 Aug 2026.